Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Active, Not Recruiting

Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax

NCT05617963

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Centre de Radiothérapie du Pays d'Aix Aix-en-Provence, France
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • Institut du Cancer Avignon-Provence Avignon, France
  • Centre d'Oncologie du Pays Basque Bayonne, France
View all 32 locations
View Trial Details
Active, Not Recruiting

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

NCT05687266

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
View all 254 locations
View Trial Details
Active, Not Recruiting

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

NCT06544655

Conditions
Advanced Solid Tumors, Brain Diseases, Bronchial Neoplasms, +33 more
Locations
  • Local Institution - 0003 Tucson, Arizona, United States
  • Local Institution - 0007 Los Angeles, California, United States
  • Local Institution - 0011 Grand Rapids, Michigan, United States
  • Local Institution - 0004 Sioux Falls, South Dakota, United States
View Trial Details
Active, Not Recruiting

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

NCT06449209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Hematology Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

NCT05633602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details

Related conditions